There is a significant and unmet need for rapid point-of-need diagnostic testing solutions, as the COVID-19 pandemic has clearly demonstrated. This need exists because it is not easy to produce point-of-need testing solutions that are fast, reliable, and cost-effective. Micromensio’s unique, scalable, bio-sensing technology platform is designed to provide the solution for rapid point-of-need diagnostics. We are partnering to deliver a rapid, high-throughput, molecular diagnostic testing solution with the capability of running 1000+ tests per day with a test kit cost significantly lower than existing solutions. This product will provide a solution for pathogen detection, including COVID-19 testing.